Research Education Core
Research Education Core
批准号:
10327915
负责人:
Shailesh Singh
金额:
$22.67万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
未结题
起止时间:
2005-09-30 至 2026-08-31
关键词:
African AmericanAgeAlabamaAptitudeBiomedical ResearchCancer Research ProjectCareer MobilityCaringClinical ResearchColorectal CancerCommunicationCommunitiesComprehensive Cancer CenterDiagnosisDiverse WorkforceEducationEducational ActivitiesEducational CurriculumEvaluationExposure toFacultyFeedbackFellowshipFundingFutureGoalsGrantHealthHealthcareHigh School StudentImmersionIncidenceInformaticsInfrastructureInstitutionInterviewJointsLaboratoriesLatinxLearningLinkMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMedicalMedical StudentsMentorsMethodsMinority GroupsMorehouse School of MedicineMovementOutcomePatientsPoliciesPostdoctoral FellowPublicationsResearchResearch PersonnelResearch Project GrantsSchoolsScienceScientistStructureStudentsTimeTrainingUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesanticancer researchbasecancer educationcancer health disparitycancer therapycancer typecareercareer developmentcollegeeducation researchethnic diversityethnic minority populationexperiencegraduate studenthands on researchhealth disparityhigh schoolimprovedinterestmembermenmortalityoutreachprogramsracial and ethnicracial and ethnic disparitiesracial diversityrecruitresponserural arearural settingskillssocial mediastatisticssummer programundergraduate studentunderserved minorityurban areaurban setting
中文摘要
摘要:研究教育核心
(This所有三个伙伴机构的核心是相同的)
莫尔豪斯医学院(MSM)/塔斯基吉大学(TU)/
亚拉巴马在伯明翰奥尼尔综合癌症中心(MSM/TU/UAB OCCC)提出了一个独特的
有机会在我们成功的成就基础上,教育未来的癌症研究科学家,
通过我们的管道,重点是代表性不足的种族/少数民族。在U 54更新中,
应用,我们提出了一个无缝集成我们的癌症教育计划,重点是“硬”
(通过以前的U 54资助开发的结构化课程/培训)和“软”技能(例如,职业生涯
发展路线图,面试技巧),以促进通过我们的管道进入癌症
研究连续体,目标是在癌症研究中拥有多样化的劳动力。这将是完成
通过以下具体目标:目标1。发展及推行综合癌症研究教育
计划将高中,本科生和研究生/医学生与博士后研究员,医学
居民,和早期研究人员(ESI),以及高级研究人员/导师,特别关注
在科学领域代表性不足的种族/族裔少数群体。将利用四个综合方案:
通过创建令人兴奋的科学学习实验室(GROW CELLS)来研究健康的机会
(B)癌症研究沉浸式学生计划(CRISP)
(c)为研究生和医科学生举办的夏季癌症研究教育方案;
和(d)健康差异研究教育计划(HDREP)的医疗居民,博士后
研究员和ESI。目标2.将各级癌症研究学者与外展核心联系起来,
与社区成员的研究结果,获得社区对相关主题的反馈,以供未来研究
(e.g.,癌症信息咖啡馆),并为非专业观众开发出版物和交流(例如,博客或帖子
社交媒体、YouTube视频、政策简报)。目标3。实施混合方法、三角评估
建议中的研究教育活动。这些努力将增加征聘工作,
保留在科学界,特别是在癌症研究中代表性不足的少数群体,这与
在NIH的多样性声明中表达的目标。
英文摘要
PROGRAM SUMMARY: RESEARCH EDUCATION CORE
(This Core is identical for all three Partnering Institutions)
The Partnership between Morehouse School of Medicine (MSM)/Tuskegee University (TU)/University of
Alabama at Birmingham O’Neal Comprehensive Cancer Center (MSM/TU/UAB OCCC) presents a distinctive
opportunity to build on our successful accomplishments in education of future cancer research scientists moving
through our pipeline, with an emphasis on underrepresented racial/ethnic minorities. In this U54 renewal
application, we propose a seamless integration of our cancer education programs by focusing on “hard”
(structured courses/training developed through previous U54 funding) and “soft” skills (e.g., career
development roadmap, interviewing skills) needed to facilitate movement through our pipeline into the cancer
research continuum, with the goal of having a diverse workforce in cancer research. This will be accomplished
through the following specific aims: Aim 1. To develop and implement integrated cancer research education
programs to link high school, undergraduate, and graduate/medical students with postdoctoral fellows, medical
residents, and Early Stage Investigators (ESIs), and senior-level researchers/mentors with a particular focus on
underrepresented racial/ethnic minorities in science. Four integrated programs will be utilized: (a) the Granting
Research Opportunities in Wellness by Creating Exciting Learning Laboratories in Science (GROW CELLS)
for high school students; (b) the Cancer Research Immersion Student Program (CRISP) for undergraduate
students; (c) the Summer Cancer Research Education Program (SCREP) for graduate and medical students;
and (d) the Health Disparities Research Education Program (HDREP) for medical residents, postdoctoral
fellows, and ESIs. Aim 2. To link all levels of cancer research scholars with the Outreach Core to share their
research findings with community members, obtain community feedback on relevant topics for future research
(e.g., Cancer Info Cafés), and develop publications and communications for lay audiences (e.g., blogs or posts
on social media, YouTube videos, policy briefs). Aim 3. To implement a mixed-method, triangulated evaluation
of the proposed research education activities across the pipeline. These efforts will increase the recruitment and
retention of underrepresented minorities in science, specifically in cancer research, that are congruent with the
goals expressed in the NIH’s Interest in Diversity Statement.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-CCL25 mAb to treat castration resistant prostate cancer
-
批准号:9264953
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2017
-
负责人:Shailesh Singh
-
依托单位:
Anti-CXCL13 mAb to mitigate prostate cancer health disparities
-
批准号:8998175
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2015
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:8918551
-
项目类别:
-
资助金额:$18.39万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:9340094
-
项目类别:
-
资助金额:$9.58万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:9137633
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:8585726
-
项目类别:
-
资助金额:$21.23万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of CCL25-CCR9 in Prostate Cancer
-
批准号:8638910
-
项目类别:
-
资助金额:$35.38万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of CCL25-CCR9 in Prostate Cancer
-
批准号:8414694
-
项目类别:
-
资助金额:$35.38万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Role of chemokine receptor in disparities associated with prostate cancer progres
-
批准号:8728793
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Prostate Cancer Chemoprevention using a Natural Agent
-
批准号:8445062
-
项目类别:
-
资助金额:$18.47万
-
财政年份:2013
-
负责人:Shailesh Singh
-
依托单位:
Research Education Core
-
批准号:10693359
-
项目类别:
-
资助金额:$22.22万
-
财政年份:2005
-
负责人:Shailesh Singh
-
依托单位:
Research Education Core
-
批准号:10007640
-
项目类别:
-
资助金额:$14.75万
-
财政年份:2005
-
负责人:Shailesh Singh
-
依托单位:
Research Education Core
-
批准号:9368967
-
项目类别:
-
资助金额:$27.48万
-
财政年份:--
-
负责人:Shailesh Singh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: